Non mechanism-specific drugs
1 paper1 finding
- 1 lab in 1 country
- Funder: European Society for Medical Oncology
- 1 of 1 finding with company ties
Outcomes
1Trial success
downin humans1OR 0.3
1 study
Trial success
downin humans1OR 0.3
Non mechanism-specific drugs decrease trial success in humans (OR 0.30, 95% CI 0.10-0.90).
Reviewlower pretrial evidence
ESMO open8 Sep 2026
Latest
1 in 12 monthsESMO Open
Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success
Systematic review of randomised trialsCancer